JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB25232

Anti-CD19 antibody [6D5]

3

(3 Reviews)

|

(23 Publications)

Rat Monoclonal CD19 antibody. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 23 publications. Immunogen corresponding to Cell preparation containing Cd19 protein.

View Alternative Names

CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, Cd19

1 Images
Flow Cytometry - Anti-CD19 antibody [6D5] (AB25232)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-CD19 antibody [6D5] (AB25232)

Flow Cytometry analysis of BALB/c mouse splenocyte cells labeling CD19 with ab25232 at 1 μg/106 cells dilution, followed by Rat Anti-Mouse CD3ε-FITC then by Mouse Anti-Rat IgG2a-PE.

  • 660 APC

    APC Anti-CD19 antibody [6D5]

  • 667 Cy5®

    Cy5 ® Anti-CD19 antibody [6D5]

  • 695 PE/Cy5.5®

    PE/Cy5.5® Anti-CD19 antibody [6D5]

  • 667 PE/Cy5®

    PE/Cy5® Anti-CD19 antibody [6D5]

  • 778 PE/Cy7®

    PE/Cy7® Anti-CD19 antibody [6D5]

Key facts

Host species

Rat

Clonality

Monoclonal

Clone number

6D5

Isotype

IgG2a

Light chain type

kappa

Carrier free

No

Reacts with

Mouse

Applications

Flow Cyt

applications

Immunogen

Cell preparation containing Cd19 protein. The exact immunogen used to generate this antibody is proprietary information.

P25918

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/rat-igg2a-kappa-monoclonal-rtk2758-isotype-control-ab18450'>ab18450</a> - Rat monoclonal IgG2a, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 8.2 Constituents: 100% Borate buffered saline
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD19 is a transmembrane protein also known as B4 or B-lymphocyte antigen CD19 with an approximate molecular weight of 95 kDa. It is expressed on the surface of B cells throughout their development from pro-B cells to mature B cells. CD19 functions mechanically as a coreceptor enhancing the sensitivity of B cell receptor (BCR) signaling. This protein plays a significant role in promoting the activation and proliferation of B cells by lowering the threshold for antigen receptor engagement.
Biological function summary

CD19 acts as an essential player in B cell signaling. CD19 integrates signals from the BCR with other coreceptors acting as a signaling hub. It participates in forming a signaling complex that includes proteins like CD21 and CD81 which further amplifies BCR-mediated signaling. This complex plays a critical role in B cell activation differentiation and survival ensuring that immune responses are efficiently mounted against pathogens.

Pathways

The CD19 protein fits into key immune response pathways such as the BCR signaling pathway and the PI3K-Akt signaling pathway. CD19 collaborates with other proteins like CD21 CD81 and PI3K within these pathways. Its interaction in the PI3K-Akt pathway for instance supports critical processes including B cell activation and homeostasis contributing to the adaptive immune response.

CD19 is connected to B cell malignancies and autoimmune diseases. B cell acute lymphoblastic leukemia (ALL) often shows aberrant CD19 expression making it a valuable target for therapeutic interventions like anti-CD19 monoclonal antibodies. Additionally overexpression or mutations of CD19 may contribute to autoimmune diseases by disrupting normal B cell regulation. CD19's connection with proteins like CD22 and CD20 in these pathological contexts highlights its relevance in developing targeted therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens (By similarity). Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores (PubMed : 12387743, PubMed : 20101619, PubMed : 9382888). Is not required for early steps during B cell differentiation in the blood marrow (PubMed : 7542548, PubMed : 7543183, PubMed : 9317126). Required for normal differentiation of B-1 cells (PubMed : 12387743, PubMed : 7542548, PubMed : 7543183). Required for normal B cell differentiation and proliferation in response to antigen challenges (PubMed : 12387743, PubMed : 7542548, PubMed : 9317126). Required for normal levels of serum immunoglobulins, and for production of high-affinity antibodies in response to antigen challenge (PubMed : 12387743, PubMed : 7542548, PubMed : 7543183).
See full target information Cd19

Publications (23)

Recent publications for all applications. Explore the full list and refine your search

Open veterinary journal 15:3558-3570 PubMed41036017

2025

Host-parasite interaction in latent cerebral toxoplasmosis: The role of cytokine response in a mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Tuğçe Anteplioğlu,Merve Bişkin Türkmen,Erva Eser,Damla Okatan,Oğuz Kul

Nature communications 14:8048 PubMed38052854

2023

Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.

Applications

Unspecified application

Species

Unspecified reactive species

Azucena Ramos,Catherine E Koch,Yunpeng Liu-Lupo,Riley D Hellinger,Taeyoon Kyung,Keene L Abbott,Julia Fröse,Daniel Goulet,Khloe S Gordon,Keith P Eidell,Paul Leclerc,Charles A Whittaker,Rebecca C Larson,Audrey J Muscato,Kathleen B Yates,Juan Dubrot,John G Doench,Aviv Regev,Matthew G Vander Heiden,Marcela V Maus,Robert T Manguso,Michael E Birnbaum,Michael T Hemann

Frontiers in cardiovascular medicine 10:1152124 PubMed37063951

2023

Injury to the tunica media initiates atherogenesis in the presence of hyperlipidemia.

Applications

Unspecified application

Species

Unspecified reactive species

Hanane Belhoul-Fakir,Jiansha Wu,Yen L Yeow,Gabrielle C Musk,Helen Kershaw,Evan Ingley,Bichen Sophie Zhao,Christopher M Reid,Christopher Lagat,Brian Evans,Peter L Thompson,Michael L Brown,Juliana Hamzah,Shirley Jansen

Molecular cancer research : MCR 21:155-169 PubMed36287175

2022

Gut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Ahmed Rokan,Juan Carlos Hernandez,Rajeshwar Nitiyanandan,Zi-Ying Lin,Chia-Lin Chen,Tatsuya Machida,Meng Li,Jasleen Khanuja,Mo Li Chen,Stanley M Tahara,Imran Siddiqi,Keigo Machida

JCI insight 7: PubMed35552285

2022

CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Masayo Ukita,Junzo Hamanishi,Hiroyuki Yoshitomi,Koji Yamanoi,Shiro Takamatsu,Akihiko Ueda,Haruka Suzuki,Yuko Hosoe,Yoko Furutake,Mana Taki,Kaoru Abiko,Ken Yamaguchi,Hidekatsu Nakai,Tsukasa Baba,Noriomi Matsumura,Akihiko Yoshizawa,Hideki Ueno,Masaki Mandai

Brain : a journal of neurology 142:2000-2012 PubMed31079141

2019

Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Maria Pia Giannoccaro,David A Menassa,Leslie Jacobson,Ester Coutinho,Gennaro Prota,Bethan Lang,M Isabel Leite,Vincenzo Cerundolo,Rocco Liguori,Angela Vincent

EBioMedicine 37:38-46 PubMed30297145

2018

In situ administration of cytokine combinations induces tumor regression in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jinyu Zhang,Haochen Jiang,Haiyun Zhang

Experimental and therapeutic medicine 16:4225-4231 PubMed30344697

2018

Tanshinone IIA improves diabetes mellitus via the NF-κB-induced AMPK signal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Feng-Yi Yuan,Min Zhang,Ping Xu,Dan Xu,Ping Chen,Min Ren,Qin Sun,Jing-Yan Chen,Juan Du,Xia-Lian Tang

FASEB journal : official publication of the Federa 32:3336-3345 PubMed29401614

2018

Depletion of microglia augments the dopaminergic neurotoxicity of MPTP.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoxia Yang,Honglei Ren,Kristofer Wood,Minshu Li,Shenfeng Qiu,Fu-Dong Shi,Cungen Ma,Qiang Liu

Journal of orthopaedic research : official publica 35:2425-2434 PubMed28263017

2017

Diminished bone regeneration after debridement of posttraumatic osteomyelitis is accompanied by altered cytokine levels, elevated B cell activity, and increased osteoclast activity.

Applications

Unspecified application

Species

Unspecified reactive species

Johannes M Wagner,Henriette Jaurich,Christoph Wallner,Stephanie Abraham,Mustafa Becerikli,Mehran Dadras,Kamran Harati,Vikas Duhan,Vishal Khairnar,Marcus Lehnhardt,Björn Behr
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com